Photo=Hyundai Motor Hyundai Motor is bringing a bold new look to the U.S. aftermarket scene with the debut of its Ioniq 9 Off-Road Conceptat SEMA 2025, the world’s largest custom and tuning car exhibition. The company aims to merge classic off-road culture with cutting-edge EV technology, targeting enthusiasts who still appreciate the rugged appeal of combustion-powered vehicles. The South Korean

(Photo=boulangerie) Imagine Jeff Bezos writing personal good-luck letters to thousands of Amazon employees’ kids before the SAT.Unlikely, right? Yet in South Korea, that’s exactly what one billionaire does — every single year. Each November, as the country braces for suneung, its ultra-high-stakes college entrance exam, Hanwha Group Chairman Kim Seung-yeon keeps a tradition that has lasted 21 years: sending handwritten

(Photo=Pixabay) South Korea’s foreign exchange reserves climbed for a fifth consecutive month in October, reaching $428 billion, the Bank of Korea said Tuesday. The $6 billion increase from September was driven by higher investment income and new issuances of foreign exchange stabilization bonds. While the numbers drew limited attention abroad, the steady rebound underscores how South Korea has been rebuilding

Pgoto=Motionelements South Korea will restructure its steel industry to address chronic oversupply and strengthen competitiveness, the Ministry of Trade, Industry and Energy (MOTIE) announced. The plan shifts the focus from mass production to high-value, low-carbon steelmaking, supported by tighter import controls, export assistance, and investments in hydrogen-based technologies. The government will cut production of low-margin products such as rebar, sections,

Close up of a syringe needle entering a vaccine vial with a red cap, representing vaccination, immunization, and medical research in healthcare. South Korea’s vaccine market is projected to expand sharply, reaching the $2 billion mark by 2029, fueled by steady post-pandemic growth and rising investment in essential vaccine R&D. According to Kim Sung-soon, director at the Infectious Disease R&D